Issue 7, 2014

Multifunctional dendrimers modified with alpha-tocopheryl succinate for targeted cancer therapy

Abstract

Generation 5 poly(amidoamine) dendrimers were used as a nanoplatform to conjugate covalently an anticancer drug, alpha-tocopheryl succinate (α-Tos) and targeting ligand folic acid (FA). The formed multifunctional dendrimers are able to endow the hydrophobic drug α-Tos with improved water solubility for targeted inhibition of cancer cells via an FA receptor-mediated targeting pathway.

Graphical abstract: Multifunctional dendrimers modified with alpha-tocopheryl succinate for targeted cancer therapy

Supplementary files

Article information

Article type
Concise Article
Submitted
27 Oct 2013
Accepted
28 Jan 2014
First published
29 Jan 2014

Med. Chem. Commun., 2014,5, 879-885

Author version available

Multifunctional dendrimers modified with alpha-tocopheryl succinate for targeted cancer therapy

Y. Zheng, F. Fu, M. Zhang, M. Shen, M. Zhu and X. Shi, Med. Chem. Commun., 2014, 5, 879 DOI: 10.1039/C3MD00324H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements